Haisco Pharmaceutical Group Co., Ltd.
Clinical trials sponsored by Haisco Pharmaceutical Group Co., Ltd., explained in plain language.
-
New inhaler tested for lung disease
Disease control OngoingThis study is testing a new inhaled medication called HSK39004 for people with COPD, a chronic lung disease. It will measure how much of the drug gets into the bloodstream and how it affects patients' breathing over 12 hours. The study involves 12 participants who will try both t…
Phase: PHASE2 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Scientists test drug mix in healthy volunteers
Knowledge-focused OngoingThis early-stage study aims to understand how a common antibiotic (rifampicin) changes the way the body processes an experimental drug called HSK31858. It involves 24 healthy volunteers who will take both drugs in a set sequence. The main goal is to measure drug levels in the blo…
Phase: PHASE1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:30 UTC
-
Scientists test drug mix in healthy volunteers
Knowledge-focused ENROLLING_BY_INVITATIONThis early-stage study aims to understand how a common antifungal medication (itraconazole) affects the way the body processes a new experimental drug (HSK31858). It involves 24 healthy volunteers who will take both drugs in a specific sequence. The main goal is to measure the le…
Phase: PHASE1 • Sponsor: Haisco Pharmaceutical Group Co., Ltd. • Aim: Knowledge-focused
Last updated Mar 09, 2026 14:25 UTC